Related Experiment Videos
[Current status of tumor markers]
Gan No Rinsho. Japan Journal of Cancer Clinics
|May 1, 1983
Summary
Tumor markers like Bence-Jones protein and alpha-fetoprotein aid cancer diagnosis. Advances in assay methods and understanding molecular differences, such as sugar chains, are crucial for cancer research.
Area of Science:
- Biochemistry
- Oncology
- Immunology
Context:
- Tumor markers are increasingly important in cancer diagnosis.
- Established markers include Bence-Jones protein, alpha-fetoprotein, CEA, gamma-GTP, and placental alkaline phosphatase.
- Hormones also function as tumor markers.
Purpose:
- To review the progress in the development and application of tumor markers for cancer diagnosis.
- To highlight advancements in assay methodologies and the characterization of tumor-associated molecules.
Summary:
- Significant progress has been made in identifying and utilizing tumor markers for cancer detection.
- Novel assay techniques, including radioimmunoassay (RIA), enzyme immunoassay (EIA), and monoclonal antibody technology, have improved detection sensitivity and specificity.
- Research is focusing on subtle molecular differences, such as variations in sugar chain structures and amino acid sequences, to discover new markers and understand cancer pathogenesis.
Impact:
- Improved diagnostic accuracy and earlier detection of various cancers.
- Enhanced understanding of cancer biology and pathogenesis.
- Development of targeted therapies and personalized treatment strategies based on specific tumor marker profiles.